Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

58.42 +0.59 (+1.02%)
Official Closing Price Updated: 4:10 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,003,298
Open 57.88
Bid (Size) 58.42 (15)
Ask (Size) 58.80 (14)
Prev. Close 57.83
Today's Range 57.75 - 59.19
52wk Range 52.77 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 4.14%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
4 Dividend Stocks to Double Up On Right Now
Dividend investing is a powerful way to build wealth and financial security. 
Via The Motley Fool
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
-27.74%
-27.74%
1 Month
-0.65%
-0.65%
3 Month
-4.25%
-4.25%
6 Month
-25.16%
-25.16%
1 Year
-17.37%
-17.37%

More News

Read More
Walgreens Agrees To $106.8M Settlement Over Alleged False Billing Claims
Via Benzinga
Topics Lawsuit Whistleblower
Exposures Financial Legal
3 Overlooked Stocks With Strong Value and Dividend Potential
Via MarketBeat
Behind the Scenes of CVS Health's Latest Options Trends
Via Benzinga
What 9 Analyst Ratings Have To Say About CVS Health
Via Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
Via Benzinga
PayPal Is A Buy, Jim Cramer Says: As For Rivian? 'Let It Percolate'
Via Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Via Benzinga
CVS Shares Are Trading Lower Wednesday: What You Need To Know
Via Benzinga
Interest Rates, Private Equity, Stocks, Football...We've Got It All
Via The Motley Fool
What the Options Market Tells Us About CVS Health
Via Benzinga
Peering Into CVS Health's Recent Short Interest
Via Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Via Benzinga
CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit With the Schall Law Firm
From The Schall Law Firm
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)
From The Law Offices of Frank R. Cruz
Via Business Wire
CVS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Rosen Law Firm Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action with an Expanded Class Period– CVS
From The Rosen Law Firm, P.A.
Via Business Wire
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
Via The Motley Fool
CVS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Down About 65% in 2024, Is Walgreens Stock a Buy on the Dip?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.